SK Bioscience Begins 2-day IPO Subscription
SEOUL, March 9 (Korea Bizwire) — South Korean vaccine maker SK Bioscience Co. on Tuesday kicked off a two-day public subscription for its initial public offering (IPO), seen as a high-profile share sale during the first half. SK Bioscience, a unit of South Korea’s No. 2 family-controlled conglomerate SK Group, has allowed individual investors to [...]